Should the Cabilly patent fall, more than its licensees will be affected.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Authors and Affiliations
Related links
Related links
Related links in Nature Research
Supreme Court boosts licensees in biotech patent battles
Web links
Rights and permissions
About this article
Cite this article
Waltz, E. Industry waits for fallout from Cabilly. Nat Biotechnol 25, 699–700 (2007). https://doi.org/10.1038/nbt0707-699
Published:
Issue Date:
DOI: https://doi.org/10.1038/nbt0707-699
This article is cited by
-
Four rebuffs for Cabilly
Nature Biotechnology (2008)